Oligonucleotide compositions and their use to induce apoptosis


Ontology type: sgo:Patent     


Patent Info

DATE

2007-04-03T00:00

AUTHORS

Nigel C. Phillips , Mario C. Filion , Zdenek Richard Holan , Stéphanie Reader

ABSTRACT

The present invention provides novel synthetic oligonucleotide sequences (hereinafter sequence) of 3 to 9 bases in length comprising one or more non-DNA bases wherein the bases are nebularine, hypoxanthine, or uracil, or combinations of nebularine, hypoxanthine and uracil bases. These sequences optionally further comprise one or more guanine bases or one or more thymine bases, or combinations thereof. The present invention also provides methods of using these compositions to induce responses in cells, and to treat diseases and conditions characterized by undesired cellular proliferation such as autoimmune disease, lymphoproliferative disease, inflammation or cancer. More... »

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "Nigel C. Phillips", 
        "type": "Person"
      }, 
      {
        "name": "Mario C. Filion", 
        "type": "Person"
      }, 
      {
        "name": "Zdenek Richard Holan", 
        "type": "Person"
      }, 
      {
        "name": "St\u00e9phanie Reader", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1006/taap.1997.8103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009474721"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/nar/14.20.8135", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017813738"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.92.20.9363", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021293422"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/07328319908044830", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023922241"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.274.37.26369", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025318715"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0304-4157(94)90001-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031407168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0304-4157(94)90001-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031407168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/372333a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031628023", 
          "https://doi.org/10.1038/372333a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.081560598", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049150821"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.91.13.5873", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053390529"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/bi00278a012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055168369"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/bi970341y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055213652"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/bi970341y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055213652"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2007-04-03T00:00", 
    "description": "

The present invention provides novel synthetic oligonucleotide sequences (hereinafter sequence) of 3 to 9 bases in length comprising one or more non-DNA bases wherein the bases are nebularine, hypoxanthine, or uracil, or combinations of nebularine, hypoxanthine and uracil bases. These sequences optionally further comprise one or more guanine bases or one or more thymine bases, or combinations thereof. The present invention also provides methods of using these compositions to induce responses in cells, and to treat diseases and conditions characterized by undesired cellular proliferation such as autoimmune disease, lymphoproliferative disease, inflammation or cancer.

", "id": "sg:patent.US-7199228-B2", "keywords": [ "oligonucleotides", "apoptosis", "invention", "synthetic oligonucleotides", "sequence", "base", "DNA base", "hypoxanthine", "uracil", "guanine", "thymine", "method", "composition", "cell", "disease", "condition", "proliferation", "autoimmune disease", "lymphoproliferative disease", "inflammation", "Neoplasm" ], "name": "Oligonucleotide compositions and their use to induce apoptosis", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.450586.a", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-7199228-B2" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:29", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_03186.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-7199228-B2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-7199228-B2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-7199228-B2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-7199228-B2'


 

This table displays all metadata directly associated to this object as RDF triples.

89 TRIPLES      15 PREDICATES      46 URIs      29 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-7199228-B2 schema:about anzsrc-for:3103
2 schema:author N3234ed7bc6c3411296483747e5e1f1c3
3 schema:citation sg:pub.10.1038/372333a0
4 https://doi.org/10.1006/taap.1997.8103
5 https://doi.org/10.1016/0304-4157(94)90001-9
6 https://doi.org/10.1021/bi00278a012
7 https://doi.org/10.1021/bi970341y
8 https://doi.org/10.1073/pnas.081560598
9 https://doi.org/10.1073/pnas.91.13.5873
10 https://doi.org/10.1073/pnas.92.20.9363
11 https://doi.org/10.1074/jbc.274.37.26369
12 https://doi.org/10.1080/07328319908044830
13 https://doi.org/10.1093/nar/14.20.8135
14 schema:datePublished 2007-04-03T00:00
15 schema:description <p num="p-0001">The present invention provides novel synthetic oligonucleotide sequences (hereinafter sequence) of 3 to 9 bases in length comprising one or more non-DNA bases wherein the bases are nebularine, hypoxanthine, or uracil, or combinations of nebularine, hypoxanthine and uracil bases. These sequences optionally further comprise one or more guanine bases or one or more thymine bases, or combinations thereof. The present invention also provides methods of using these compositions to induce responses in cells, and to treat diseases and conditions characterized by undesired cellular proliferation such as autoimmune disease, lymphoproliferative disease, inflammation or cancer.</p>
16 schema:keywords DNA base
17 Neoplasm
18 apoptosis
19 autoimmune disease
20 base
21 cell
22 composition
23 condition
24 disease
25 guanine
26 hypoxanthine
27 inflammation
28 invention
29 lymphoproliferative disease
30 method
31 oligonucleotides
32 proliferation
33 sequence
34 synthetic oligonucleotides
35 thymine
36 uracil
37 schema:name Oligonucleotide compositions and their use to induce apoptosis
38 schema:recipient https://www.grid.ac/institutes/grid.450586.a
39 schema:sameAs https://app.dimensions.ai/details/patent/US-7199228-B2
40 schema:sdDatePublished 2019-04-18T10:29
41 schema:sdLicense https://scigraph.springernature.com/explorer/license/
42 schema:sdPublisher N5bf252ff3bc84dbc94c1920039a43845
43 sgo:license sg:explorer/license/
44 sgo:sdDataset patents
45 rdf:type sgo:Patent
46 N0dc5bc6c31164eefbf8d6d3d3cb28b56 rdf:first N7501cb95a7f24a49b17086ab9cd424b0
47 rdf:rest rdf:nil
48 N20d5503f67774673a066b061cd8e85de schema:name Mario C. Filion
49 rdf:type schema:Person
50 N3234ed7bc6c3411296483747e5e1f1c3 rdf:first Nc9275e8cd61c456f97042efcf124bec1
51 rdf:rest N42dddd07f10642beb2cb77ee72cba387
52 N42dddd07f10642beb2cb77ee72cba387 rdf:first N20d5503f67774673a066b061cd8e85de
53 rdf:rest Nf4b4177ae5bf4790bf8b8e15ee962305
54 N5bf252ff3bc84dbc94c1920039a43845 schema:name Springer Nature - SN SciGraph project
55 rdf:type schema:Organization
56 N7501cb95a7f24a49b17086ab9cd424b0 schema:name Stéphanie Reader
57 rdf:type schema:Person
58 Nc9275e8cd61c456f97042efcf124bec1 schema:name Nigel C. Phillips
59 rdf:type schema:Person
60 Ndbee2ce7cfee427b83e5d5020d83695f schema:name Zdenek Richard Holan
61 rdf:type schema:Person
62 Nf4b4177ae5bf4790bf8b8e15ee962305 rdf:first Ndbee2ce7cfee427b83e5d5020d83695f
63 rdf:rest N0dc5bc6c31164eefbf8d6d3d3cb28b56
64 anzsrc-for:3103 schema:inDefinedTermSet anzsrc-for:
65 rdf:type schema:DefinedTerm
66 sg:pub.10.1038/372333a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031628023
67 https://doi.org/10.1038/372333a0
68 rdf:type schema:CreativeWork
69 https://doi.org/10.1006/taap.1997.8103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009474721
70 rdf:type schema:CreativeWork
71 https://doi.org/10.1016/0304-4157(94)90001-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031407168
72 rdf:type schema:CreativeWork
73 https://doi.org/10.1021/bi00278a012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055168369
74 rdf:type schema:CreativeWork
75 https://doi.org/10.1021/bi970341y schema:sameAs https://app.dimensions.ai/details/publication/pub.1055213652
76 rdf:type schema:CreativeWork
77 https://doi.org/10.1073/pnas.081560598 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049150821
78 rdf:type schema:CreativeWork
79 https://doi.org/10.1073/pnas.91.13.5873 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053390529
80 rdf:type schema:CreativeWork
81 https://doi.org/10.1073/pnas.92.20.9363 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021293422
82 rdf:type schema:CreativeWork
83 https://doi.org/10.1074/jbc.274.37.26369 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025318715
84 rdf:type schema:CreativeWork
85 https://doi.org/10.1080/07328319908044830 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023922241
86 rdf:type schema:CreativeWork
87 https://doi.org/10.1093/nar/14.20.8135 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017813738
88 rdf:type schema:CreativeWork
89 https://www.grid.ac/institutes/grid.450586.a schema:Organization
 




Preview window. Press ESC to close (or click here)


...